U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
160219160219Phase 3 Immunogenicity and Safety Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)CompletedNo Results AvailableInfluenzaBiological: Whole virion, Vero cell-derived influenza vaccine containing H5N1 HA antigen|Biological: Whole virion, Vero cell-derived influenza vaccine containing H5N1 HA antigen|Biological: Whole virion, Vero cell-derived influenza vaccine containing H5N1 HA antigen|Biological: Whole virion, Vero cell-derived influenza vaccine containing H5N1 HA antigen|Biological: Whole virion, Vero cell-derived influenza vaccine containing H5N1 HA antigen|Biological: Whole virion, Vero cell-derived influenza vaccine containing H5N1 HA antigenhttps://ClinicalTrials.gov/show/NCT00462215
160220160220Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong KongTerminatedNo Results AvailableDiabetic NephropathyDrug: sulodexide|Drug: Sulodexidehttps://ClinicalTrials.gov/show/NCT00462202
160221160221Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance DiseaseRecruitingNo Results AvailableLeukemia|Hairy Cell Leukemia|HCLDrug: Immunotoxin therapy|Drug: CAT-8015 Immunotoxin|Procedure: Biological therapyhttps://ClinicalTrials.gov/show/NCT00462189
160222160222Laparoscopic Segmental Bowel Resection for Deep Infiltrating Colorectal EndometriosisCompletedNo Results AvailableEndometriosisProcedure: multidisciplinary laparoscopy|Other: Questionnaireshttps://ClinicalTrials.gov/show/NCT00462176
160223160223Effects of Home-Based Emotional Disclosure in Rheumatoid ArthritisCompletedNo Results AvailableRheumatoid ArthritisBehavioral: home-based emotional disclosure|Behavioral: time management control conditionhttps://ClinicalTrials.gov/show/NCT00462150
160224160224The Influence of Hypnotic Medications on Sleep Arousal and Its Effect on Gastroesophageal RefluxCompletedNo Results AvailableGastroesophageal RefluxProcedure: Sleep Studieshttps://ClinicalTrials.gov/show/NCT00462137
160225160225Evaluation of the Safety and Efficacy of the BioProtect Balloon in Prostate Cancer Subjects Undergoing RadiotherapyRecruitingNo Results AvailableProstate CancerDevice: BioProtect biodegradable balloon implant|Device: Ballon implantationhttps://ClinicalTrials.gov/show/NCT00462124
160226160226Indomethacin and Mechanisms Underlying Risk of FallingCompletedNo Results AvailableHealthyDrug: Indometacinhttps://ClinicalTrials.gov/show/NCT00462111
160227160227Randomized Controlled Trial of Hyperbaric Oxygen in Patients Who Have Taken BisphosphonatesCompletedNo Results AvailableOsteonecrosisDevice: hyperbaric oxygen|Device: non-treated control grouphttps://ClinicalTrials.gov/show/NCT00462098
160228160228Muscle Activity With the Use of Ankle Foot Orthoses in Cerebral PalsyCompletedNo Results AvailableCerebral Palsyhttps://ClinicalTrials.gov/show/NCT00462085
160201160201Systemic and Local Diffusion of Ethanol After Administration of Ethanol 96% Formulated in a Gel and Ethanol 98% Solution by the Percutaneous Route, in Patients With Congenital Venous Malformations:Pharmacokinetic, Pharmacodynamic and Clinical Study.CompletedHas ResultsCongenital Venous MalformationDrug: Ethanol 96% Gel|Drug: Ethanol 98% Solutionhttps://ClinicalTrials.gov/show/NCT00462462
160229160229Centocor Microarray Study of PatientsCompletedHas ResultsRheumatoid Arthritis|Psoriatic Arthritis|Psoriasis|Crohn's DiseaseDrug: Infliximabhttps://ClinicalTrials.gov/show/NCT00462072
160230160230Assessment of a Medication Reconciliation Program on Transitional CareCompletedNo Results AvailableHospitalizationBehavioral: Treatmenthttps://ClinicalTrials.gov/show/NCT00462059
160202160202Efficacy of Functional Electrical Stimulation (FES) in Persons Receiving Botulinum Neurotoxin for Upper Extremity SpasticityCompletedHas ResultsUpper Extremity Spasticity|Stroke|Acquired Brain InjuryDevice: Functional Electrical Stimulation (FES) through the Ness H200https://ClinicalTrials.gov/show/NCT00462449
160203160203Innovative Strategies For Risk Reduction Following CABGCompletedNo Results AvailableCoronary Artery Disease|Type II Diabetes MellitusBehavioral: Consumption of Dietary Portfoliohttps://ClinicalTrials.gov/show/NCT00462436
160204160204Abraxane and Avastin as Therapy for Patients With Malignant Melanoma, a Phase II StudyCompletedHas ResultsMetastatic Malignant MelanomaDrug: Avastin|Drug: Abraxanehttps://ClinicalTrials.gov/show/NCT00462423
160205160205Effect of Advertisements on Treatment Compliance in Women With Breast CancerCompletedNo Results AvailableBreast CancerOther: counseling intervention|Procedure: psychosocial assessment and carehttps://ClinicalTrials.gov/show/NCT00462410
160206160206Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical CancerRecruitingNo Results AvailableCervical CancerDrug: carboplatin|Drug: cisplatin|Drug: paclitaxel|Procedure: neoadjuvant therapy|Radiation: brachytherapy|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00462397
160207160207A Study of Subcutaneous Mircera for the Treatment of Anemia in Pre-Dialysis Patients With Chronic Kidney Disease.CompletedNo Results AvailableAnemiaDrug: methoxy polyethylene glycol-epoetin beta [Mircera]https://ClinicalTrials.gov/show/NCT00462384
160208160208Comparison Between Insulin Pump Treatment and Multiple Daily Insulin Injections in Diabetic Type 1 ChildrenCompletedNo Results AvailableDiabetes Mellitus, Type 1|ChildDevice: Insulin pump (CSII)https://ClinicalTrials.gov/show/NCT00462371
160209160209A Study of ARRY-520 in Patients With Advanced CancerCompletedNo Results AvailableAdvanced Solid TumorsDrug: ARRY-520, KSP(Eg5) inhibitor; intravenous|Drug: Filgrastim, granulocyte-colony stimulating factor (G-CSF); subcutaneoushttps://ClinicalTrials.gov/show/NCT00462358
160210160210A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNF Therapies.CompletedHas ResultsRheumatoid ArthritisDrug: rituximab|Drug: Methotrexate|Drug: Corticosteroid or NSAID|Dietary Supplement: Folatehttps://ClinicalTrials.gov/show/NCT00462345
160211160211Fludarabine and Alemtuzumab or Cyclophosphamide Followed by Peripheral Blood Stem Cell Transplant or Alemtuzumab in Treating Patients With Advanced or Progressive Chronic Lymphocytic LeukemiaCompletedHas ResultsLeukemiaDrug: Fludarabine|Drug: Campath|Procedure: Transplant|Drug: Campath|Drug: Fludarabine|Drug: Campath|Drug: Campathhttps://ClinicalTrials.gov/show/NCT00462332
160212160212ARTIST: ARThrose Intervention STandardiséeCompletedNo Results AvailableKnee OsteoarthritisBehavioral: Education, weight reduction and physical exercisehttps://ClinicalTrials.gov/show/NCT00462319
160213160213Incidence of Obstructive Sleep Apnea in PregnancyCompletedHas ResultsObstructive Sleep Apnea|PregnancyProcedure: Survey: Berlin questionnairehttps://ClinicalTrials.gov/show/NCT00462306
160214160214Lovastatin in Treating Patients At High Risk of MelanomaCompletedHas ResultsPrecancerous Condition|Stage 0 Melanoma|Stage I Melanoma|Stage II MelanomaDrug: lovastatin|Other: placebo|Procedure: biopsy|Procedure: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00462280
160215160215Examining the Feasibility of Collaborative Care Treatment for Overweight AdolescentsCompletedNo Results AvailableObesity|OverweightBehavioral: Enriched lifestyle interventionhttps://ClinicalTrials.gov/show/NCT00462267
160216160216Ramelteon (ROZEREM) in the Treatment of Sleep Disturbances Associated With Parkinson's DiseaseTerminatedNo Results AvailableParkinson's DiseaseDrug: ROZEREM|Drug: Ramelteonhttps://ClinicalTrials.gov/show/NCT00462254
160217160217Treatment Study Comparing Manual Treatment or Advice in Acute, Musculoskeletal Chest PainCompletedNo Results AvailableMusculoskeletal Chest Pain|Non-cardiac Chest Pain|Undiagnosed Chest PainProcedure: chiropractic treatment|Other: Self-managementhttps://ClinicalTrials.gov/show/NCT00462241
160218160218Effect of Namenda on Short Term Memory and Attention in Patients With Mild to Moderate Traumatic Brain InjuryTerminatedHas ResultsTraumatic Brain InjuryDrug: memantine|Drug: placebohttps://ClinicalTrials.gov/show/NCT00462228

* Görseller ve İçerik tekif hakkına sahip olabilir